Back to Newsroom

Curis Reports Third Quarter 2016 Financial Results

LEXINGTON, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) — Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers, today reported its financial results for the third quarter ended September 30, 2016.

Click here to read the full release